Stay informed with the latest litigation news. Explore now

IP Verse

Composition Comprising Hmos For The Treatment Of Non-Infectious Diarrhoea - EP3452050B1

EP3452050

GLYCOM
Application Number
EP17792540A
Filing Date
May 5, 2017
Status
Granted And Under Opposition
Oct 21, 2022
Grant Date
Nov 23, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3277287B8
EP3209673B2
EP3368047B1

Bibliography

The patent EP3452050B1 was granted to Glycom on Nov 23, 2022 following the initial filing on May 5, 2017 under the application number EP17792540A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

WEICKMANN & WEICKMANNAug 23, 2023ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents